Медицинская литература. Новинки

 

 

 

 

 

 

ТЕРМИНОЛОГИЧЕСКИЕ И КЛАССИФИКАЦИОННЫЕ АСПЕКТЫ БЕТЕСТОВСКОЙ СИСТЕМЫ КЛАССИФИЦИРОВАНИЯ ЦИТОЛОГИЧЕСКИХ ЗАКЛЮЧЕНИЙ ЩИТОВИДНОЙ ЖЕЛЕЗЫ

Вы можете загрузить полный текст статьи в формате pdf

Статья посвящена возможностям применения Бетестовской системы интерпретации результатов тонкоигольной аспирационной биопсии (ТАБ). Представлены современные данные об основных отличиях, а также преимуществах новой классификации. Применение Бетестовской системы классифицирования приводит к повышению чувствительности и специфичности ТАБ

Ключевые слова:
щитовидная железа, ТАБ, цитологическое заключение.

Литература:
1. Abele J.S., Levine R.A. Diagnostic criteria and risk-adapted
approach to indeterminate thyroid cytodiagnosis. Cancer
Cytopathol. 2010; 118: 415–422.
2. American Association of Clinical Endocrinologists and
Associazione Medici Endocrinologi medical guidelines for clinical
practice for the diagnosis and management of thyroid nodules.
Endocrinol. Pract. 2006; 12: 63–103.
3. Baloch Z.W., Livolsi V.A., Asa S.L. et al. Diagnostic terminology
and morphological criteria for cytologic diagnosis of thyroid
lesions: a synopsis of the National Cancer Institute thyroid fine-needle aspiration state of the science conference. Diagn.
Cytopathol. 2008; 36: 425–433.
4. Caraci P., Aversa S., Mussa A. et al. Role of fineneedle aspiration
biopsy and frozensection evaluation in the surgical management
of thyroid nodules. Br. J. Surg. 2002; 89: 797–701.
5. Cibas E.S., Alexander E.K., Benson C.B. et al. Indications for
Thyroid FNA and PreFNA Requirements: A Synopsis of the
National Cancer Institute Thyroid FineNeedle Aspiration State
of the Science Conference. Diagn. Cytopathol. 2008; 36: 390–399.
6. Cibas E.S., Ali S.Z. The Bethesda System for Reporting Thyroid
Cytopathology. Am. J. Clin. Pathol. 2009; 132: 658–665.
7. Cooper D.S., Doherty G.M., Haugen B.R. et al. Management
Guidelines for Patients with Thyroid Nodules and Differentiated
Thyroid Cancer. The American Thyroid Association Guidelines
Taskforce. Thyroid. 2006; 16: 1–33.
8. Duek S.D., Goldenberg D., Linn S. et al. The role of fineneedle aspiration and intraoperative frozen section in the surgical management of solitary thyroid nodules. Surg. Today. 2002; 32: 857–861.
9. Jo V.Y., Van der Laan P.A., Marqusee E., Krane J.F. Repeatedly
Nondiagnostic Thyroid FineNeedle Aspirations Do Not Modify
Malignancy Risk. Acta Cytol. 2011; 55: 539–543.
10. Koen T.M., Mody D.R., Scheiber-Pacht M. et al. Limiting the use of
atypical/inconclusive as a category in nongynecologic cytology
specimens. Arch. Pathol. Lab. Med. 2010; 134: 1016–1019.
11. Luu M.H., Fischer A.H., Stockl T.J. et al. Atypical Follicular Cells
with Equivocal Features of Papillary Thyroid Carcinoma Is Not a
LowRisk Cytologic Diagnosis. Acta Cytol. 2011; 55: 526–530.
12. Marchevsky A.M., Walts A.E., Bose S. et al. Evidence-based evaluation of the risks of malignancy predicted by thyroid fine-needle
aspiration biopsies. Diagn. Cytopathol. 2010; 38: 252–259.
13. Nayar R., Ivanovic M. The indeterminate thyroid fine-needle aspiration: experience from an academic center using terminology
similar to that proposed in the 2007 National Cancer Institute
Thyroid Fine Needle Aspiration State of the Science Conference.
Cancer Cytopathol. 2009; 117: 195–202.
14. NCI Thyroid Fine Needle Aspiration State of Science Conference.
Diagn. Cytopathol. 2008; 6: 388–448.
15. Ohori N.P., Schoedel K.E. Variability in the Atypia of
Undetermined Significance/Follicular Lesion of Undetermined
Significance Diagnosis in the Bethesda System for Reporting
Thyroid Cytopathology: Sources and Recommendations. Acta
Cytol. 2011; 55: 492–498.
16. Olson M.T., Clark D.P., Erozan Y.S., Ali S.Z. Spectrum of Risk of
Malignancy in Subcategories of ‘Atypia of Undetermined
Significance’. Acta Cytol. 2011; 5: 518–525.
17. Pu R.T., Yang J., Wasserman P.G. et al. Does Hurthle cell
lesion/neoplasm predict malignancy more than follicular
lesion/neoplasm on thyroid fine-needle aspiration? Diagn.
Cytopathol. 2006; 34: 330–334.
18. Renshaw A.A. Should ‘atypical follicular cells’ in thyroid fine-needle aspirates be subclassified? Cancer Cytopathol. 2010; 118:
186–189.
19. Sebo T.J. What are the keys to successful thyroid FNA interpretation? Clin. Endocrinol. 2012; 77: 13–17.
20. Somma J., Schlecht N.F., Fink D. et al. Thyroid fine needle aspiration cytology: follicular lesions and the gray zone. Acta Cytol.
2010; 54: 123–131.
21. Theoharis C.G.A., Schofield K.M., Hammers L. et al. The Bethesda
Thyroid FineNeedle Aspiration Classification System: Year 1 at
an Academic Institution. Thyroid. 2009; 19: 1215–1226.
22. Van der Laan P.A., Marqusee E., Krane J.F. Clinical outcome for
atypia of undetermined significance in thyroid fine-needle aspirations: should repeated FNA be the preferred initial approach? Am.
J. Clin. Pathol. 2011; 135: 770–775.
23. Van der Laan P.A., Renshaw A.A., Krane J.F. Atypia of undetermined significance and nondiagnostic rates in the Bethesda system
for reporting thyroid cytopathology are inversely related. Am. J.
Clin. Pathol. 2012; 137: 462–465.
24. Wang C.C., Friedman L., Kennedy G.C. et al. A large multicenter
correlation study of thyroid nodule cytopathology and histopathology. Thyroid. 2011; 21: 243–251.
25. Yang J., Schnadig V., Logrono R., Wasserman P.G. Fine-needle
aspiration of thyroid nodules: a study of 4703 patients with histologic and clinical correlations. Cancer. 2007; 111: 306–315.
26. Yassa L., Cibas E.S., Benson C.B. et al. Long-term assessment of
a multidisciplinary approach to thyroid nodule diagnostic evaluation. Cancer. 2007; 111: 508–516.
27. Gia-Khanh N., Lee M.W., Ginsberg J., Wragg T. Darcy Bilodeau
Fine-needle aspiration of the thyroid: an overview. CytoJournal.
2005; 2: 12.
28. Ali S.Z., Cibas E.S., eds. Atlas ''The Bethesda System for Reporting
Thyroid Cytopathology''. New York: Springer, 2010.

Terminology and classification aspects of the Bethesda System for Reporting Thyroid Cytopathology

The article is devoted to the relevance of Betesda System for Reporting Thyroid Cytopathology. This article summarizes recent data on the main differences and advantages of new classification system. Application of the Betesda System for Reporting Thyroid Cytopathology leads to the increased sensitivity and specificity of FNA.

Keywords:
thyroid, FNA, cytologic diagnosis